ERLIN2 and breast carcinoma: Next, we performed a 50-day breast tumor xenograft study with nude mice to assess the impact of ERLIN2 knockdown in breast cancer malignancy in vivo. ERLIN2-knockdown and control SUM225 cells were orthotopically implanted into the mammary fat pads of the left and right flanks, respectively, of NOD/SCID mice.